生物学的安全性試験用製品・サービス市場規模、製品別、用途別、試験別、地域別セグメント：動向分析レポート 2024年～2030年

生物学的安全性試験用製品・サービス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の生物学的安全性試験用製品・サービス市場規模は、2024年から2030年にかけて10.7%のCAGRを記録し、2030年には93億米ドルに達すると予測されています。

同市場は、生物製剤の生産が増加していることが主な要因となっており、非常に効果的な生物学的安全性試験ツールの需要を押し上げています。疾病負担の増加は、生物製剤の生産増加の主な要因であり、それによって市場成長が促進されると予想されます。

糖尿病やがんなど、ライフスタイルに関連する慢性疾患の有病率の増加は、医薬品開発とそれに続く商業化の増加に寄与する主な要因です。このため、特殊な標的治療の安全性を確保・精査し、成果を評価し、起こりうる欠点を回避する必要性が高まると予想されます。さらに、バイオテクノロジーおよび製薬会社は、標的疾患に苦しむ多数の人々に対応するため、汚染のない高活性の生物製剤を製造する生物学的安全性試験用製品・サービスをますます統合するようになっています。ウイルス性疾患に対する安全性試験は、生物製剤の製造、化学、管理の重要な要素であるため、多くの企業にとって主要な関心事の一つとなっています。これが市場の成長機会に拍車をかけています。

研究室ベースの汚染は、生物学的安全性製品やサービスを組み込んだワークステーションの開発と改良につながっています。組織培養を扱い、細胞株の無菌性を維持し、交差汚染を最小限に抑える必要性が高まっているため、製品の完全性に関する懸念が高まっています。適正製造基準（GMP）の実施と、それに続く各生産段階での試験・管理に対する政府ヘルスケア機関の関与の高まりは、成長の幅を広げると予想されます。

さらに、生物学的安全性試験用製品・サービス市場で事業を展開する主な企業は、生物学的安全性試験に対する世界の需要の高まりに対応するため、常に新しい製品や技術の開発、製品ポートフォリオのさらなる拡充に注力しています。例えば、2022年12月、-Charles River Laboratories International, Inc.は、水試験、工程内試験、最終製品試験のための複雑な希釈液または原液の連続希釈液の両方を処理できる完全ロボット装置であるEndosafe Nexus 200の発売を発表し、エンドトキシン試験のポートフォリオをさらに拡大しました。ロボットによる自動化を取り入れることで、品質管理プロセスを合理化し、ひいては全体的なプロセス効率を向上させることが可能になった。

生物学的安全性試験用製品・サービス市場のレポートハイライト

• 製品別では、試薬・キット分野が、研究・臨床ラボでの広範な使用により、2023年には39.9%超の主要収益シェアを占めました。
• 用途別では、ワクチン・治療薬分野が2023年の市場シェアで優位を占め、長年にわたる疾病発生の増加に起因して、最も速い成長率で成長すると予測されます。
• 検査タイプ別では、細菌感染症の増加により、エンドトキシン検査分野が2023年の市場シェアで優位を占めました。
• 北米は、バイオテクノロジーへの研究投資の増加と慢性疾患の負担の増加により、2023年の収益シェア35.13％で市場全体を支配しました。このため、同地域では予測期間中に分子細胞遺伝学に対する需要が増加すると予測されています。
• アジア太平洋地域は、インドや中国のような発展途上国におけるヘルスケア支出の増加やヘルスケアインフラの整備により、予測期間中に最も速い成長率で成長すると予測されています。

目次

第1章 調査手法と範囲

第2章 生物学的安全性試験用製品・サービス市場：エグゼクティブサマリー

• 市場スナップショット
• 製品とサービスのスナップショット
• 用途と最終用途のスナップショット
• 競合情勢のスナップショット

第3章 生物学的安全性試験用製品・サービスの市場変数、動向、および範囲

• 市場セグメンテーションと範囲
• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
• 市場促進要因分析
  • 政府の取り組みや勧告の数を増やす
  • 高い疾病負担による新しい生物製剤の生産の増加
  • 臨床調査とライフサイエンス調査への多額の研究開発投資
• 市場抑制要因分析
  • 時間のかかる承認プロセス
• 生物学的安全性試験用製品・サービス市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTLE分析

第4章 生物学的安全性試験用製品・サービス市場：製品推定・動向分析

• 製品市場シェア、2023年と2030年
• セグメントダッシュボード
• 製品別の世界の生物学的安全性試験用製品・サービス市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第5章 生物学的安全性試験用製品・サービス市場：用途の推定・動向分析

• 用途市場シェア、2023年と2030年
• セグメントダッシュボード
• 用途別の世界の生物学的安全性試験用製品・サービス市場の見通し
• 市場規模、予測、動向分析、2018年から2030年まで

第6章 生物学的安全性試験用製品・サービス市場：試験タイプの推定・動向分析

• テストタイプの市場シェア、2023年および2030年
• セグメントダッシュボード
• 試験タイプ別の世界の生物学的安全性試験用製品・サービス市場の見通し
• 市場規模、予測、動向分析、2018年から2030年まで

第7章 地域ビジネス分析

• 地域市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • 韓国
  • タイ
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
• ベンダー情勢
  • List of Key Distributors And Channel Partners
  • Key Customers
  • Key Company Market Share Analysis, 2023
  • Charles River Laboratories
  • BSL Bioservice
  • Merck KGaA
  • Samsung Biologics
  • Sartorius AG
  • Eurofins Scientific
  • SGS Societe Generale de Surveillance SA
  • Thermo Fisher Scientific Inc.
  • BIOMERIEUX
  • Lonza

List of Tables

• Table 1 List of abbreviations
• Table 2 North America Biological Safety Testing Products & Services Market, by region, 2018 - 2030 (USD Million)
• Table 3 North America Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 4 North America Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 5 North America Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 6 U.S. Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 7 U.S. Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 8 U.S. Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 9 Canada Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 10 Canada Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 11 Canada Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 12 Europe Biological Safety Testing Products & Services Market, by region, 2018 - 2030 (USD Million)
• Table 13 Europe Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 14 Europe Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 15 Europe Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 16 UK Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 17 UK Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 18 UK Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 19 Germany Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 20 Germany Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 21 Germany Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 22 France Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 23 France Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 24 France Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 25 Italy Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 26 Italy Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 27 Italy Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 28 Spain Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 29 Spain Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 30 Spain Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 31 Sweden Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 32 Sweden Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 33 Sweden Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 34 Norway Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 35 Norway Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 36 Norway Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 37 Denmark Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 38 Denmark Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 39 Denmark Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific Biological Safety Testing Products & Services Market, by region, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 44 Japan Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 45 Japan Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 46 Japan Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 47 China Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 48 China Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 49 China Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 50 India Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 51 India Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 52 India Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 53 Australia Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 54 Australia Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 55 Australia Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 56 South Korea Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 57 South Korea Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 58 South Korea Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 59 Thailand Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 60 Thailand Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 61 Thailand Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 62 Latin America Biological Safety Testing Products & Services Market, by region, 2018 - 2030 (USD Million)
• Table 63 Latin America Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 64 Latin America Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 65 Latin America Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 66 Brazil Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 67 Brazil Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 68 Brazil Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 69 Argentina Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 70 Argentina Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 71 Argentina Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 72 Mexico Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 73 Mexico Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 74 Mexico Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 75 MEA Biological Safety Testing Products & Services Market, by region, 2018 - 2030 (USD Million)
• Table 76 MEA Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 77 MEA Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 78 MEA Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 79 South Africa Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 80 South Africa Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 81 South Africa Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 85 UAE Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 86 UAE Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 87 UAE Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)
• Table 88 Kuwait Biological Safety Testing Products & Services Market, by Product, 2018 - 2030 (USD Million)
• Table 89 Kuwait Biological Safety Testing Products & Services Market, by Application, 2018 - 2030 (USD Million)
• Table 90 Kuwait Biological Safety Testing Products & Services Market, Test type, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market Research Process
• Fig. 2 Data Triangulation Techniques
• Fig. 3 Primary Research Pattern
• Fig. 4 Primary Interviews In North America
• Fig. 5 Primary Interviews In Europe
• Fig. 6 Primary Interviews In APAC
• Fig. 7 Primary Interviews In Latin America
• Fig. 8 Primary Interviews In MEA
• Fig. 9 Market Research Approaches
• Fig. 10 Value-Chain-Based Sizing & Forecasting
• Fig. 11 QFD Modeling For Market Share Assessment
• Fig. 12 Market Formulation & Validation
• Fig. 13 Biological Safety Testing Products & Services Market: Market Outlook
• Fig. 14 Biological Safety Testing Products & Services Competitive Insights
• Fig. 15 Parent Market Outlook
• Fig. 16 Related/Ancillary Market Outlook
• Fig. 17 Penetration And Growth Prospect Mapping
• Fig. 18 Industry Value Chain Analysis
• Fig. 19 Biological Safety Testing Products & Services Market Driver Impact
• Fig. 20 Biological Safety Testing Products & Services Market Restraint Impact
• Fig. 21 Biological Safety Testing Products & Services Market Strategic Initiatives Analysis
• Fig. 22 Biological Safety Testing Products & Services Market: Product Movement Analysis
• Fig. 23 Biological Safety Testing Products & Services Market: Product Outlook And Key Takeaways
• Fig. 24 Reagents & Kits Market Estimates And Forecast (USD Million, 2018 - 2030)
• Fig. 25 Services Estimates And Forecast (USD Million, 2018 - 2030)
• Fig. 26 Instruments Estimates And Forecast (USD Million, 2018 - 2030)
• Fig. 27 Biological Safety Testing Products & Services Market: Application Movement Analysis
• Fig. 28 Biological Safety Testing Products & Services Market: Application Outlook And Key Takeaways
• Fig. 29 Vaccines & therapeutics Market Estimates And Forecasts (USD Million, 2018 - 2030)
• Fig. 30 Blood & Blood-based Products Market Estimates And Forecasts (USD Million, 2018 - 2030)
• Fig. 31 Gene Therapy Market Estimates And Forecasts (USD Million, 2018 - 2030)
• Fig. 32 Tissue & Tissue-based Products Market Estimates And Forecasts (USD Million, 2018 - 2030)
• Fig. 33 Stem Cell Market Estimates And Forecasts (USD Million, 2018 - 2030)
• Fig. 34 Biological Safety Testing Products & Services Market: Test Type Movement Analysis
• Fig. 35 Biological Safety Testing Products & Services Market: End-use Outlook And Key Takeaways
• Fig. 36 Endotoxin Tests Market Estimates And Forecasts (USD Million, 2018 - 2030)
• Fig. 37 Sterility Tests Market Estimates And Forecasts (USD Million, 2018 - 2030)
• Fig. 38 Cell Line Authentication & Characterization Tests Market Estimates And Forecasts (USD Million, 2018 - 2030)
• Fig. 39 Bioburden Tests Market Estimates And Forecasts (USD Million, 2018 - 2030)
• Fig. 40 Adventitious Agent Detection Tests Market Estimates And Forecasts (USD Million, 2018 - 2030)
• Fig. 41 Residual Host Contamination Detection Tests Market Estimates And Forecasts (USD Million, 2018 - 2030)
• Fig. 42 Other Test Types Market Estimates And Forecasts (USD Million, 2018 - 2030)
• Fig. 43 Global Biological Safety Testing Products & Services Market: Regional Movement Analysis
• Fig. 44 Global Biological Safety Testing Products & Services Market: Regional Outlook And Key Takeaways
• Fig. 45 Global Biological Safety Testing Products & Services Market Share And Leading Players
• Fig. 46 North America Market Share And Leading Players
• Fig. 47 Europe Market Share And Leading Players
• Fig. 48 Asia Pacific Market Share And Leading Players
• Fig. 49 Latin America Market Share And Leading Players
• Fig. 50 Middle East & Africa Market Share And Leading Players
• Fig. 51 North America: SWOT
• Fig. 52 Europe SWOT
• Fig. 53 Asia Pacific SWOT
• Fig. 54 Latin America SWOT
• Fig. 55 MEA SWOT
• Fig. 56 North America, By Country
• Fig. 57 North America
• Fig. 58 North America Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 59 U.S.
• Fig. 60 U.S. Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 61 Canada
• Fig. 62 Canada Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 63 Europe
• Fig. 64 Europe Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 65 UK
• Fig. 66 UK Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 67 Germany
• Fig. 68 Germany Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 69 France
• Fig. 70 France Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 71 Italy
• Fig. 72 Italy Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 73 Spain
• Fig. 74 Spain Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 75 Denmark
• Fig. 76 Denmark Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 77 Sweden
• Fig. 78 Sweden Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 79 Norway
• Fig. 80 Norway Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 81 Asia Pacific
• Fig. 82 Asia Pacific Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 83 China
• Fig. 84 China Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 85 Japan
• Fig. 86 Japan Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 87 India
• Fig. 88 India Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 89 Thailand
• Fig. 90 Thailand Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 91 South Korea
• Fig. 92 South Korea Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 93 Australia
• Fig. 94 Australia Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 95 Latin America
• Fig. 96 Latin America Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 97 Brazil
• Fig. 98 Brazil Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 99 Mexico
• Fig. 100 Mexico Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 101 Argentina
• Fig. 102 Argentina Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 103 Middle East And Africa
• Fig. 104 Middle East And Africa Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 105 South Africa
• Fig. 106 South Africa Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 107 Saudi Arabia
• Fig. 108 Saudi Arabia Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 109 UAE
• Fig. 110 UAE Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 111 Kuwait
• Fig. 112 Kuwait Market Estimates And Forecasts, (USD Million, 2018 - 2030)
• Fig. 113 Market Share Of Key Market Players - Biological Safety Testing Products & Services Market

Biological Safety Testing Products And Services Market Growth & Trends:

The global biological safety testing products and services market size is expected to reach USD 9.30 billion by 2030, registering a CAGR of 10.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is predominantly driven by the increasing production of biologics, boosting the demand for highly effective biological safety testing tools. The increasing disease burden is expected to be a major factor responsible for the rising production of biologics, thereby propelling the market growth.

The increasing prevalence of chronic diseases associated with lifestyle, including diabetes and cancer, is a key factor contributing to the rise in drug development and subsequent commercialization. This is expected to increase the need for ensuring & scrutinizing the safety of specialized and targeted therapies, evaluating outcomes, and circumventing probable shortcomings. In addition, biotechnology and pharmaceutical companies are increasingly integrating biological safety testing products and services to produce contamination-free and highly potent biologics to cater to the large number of people suffering from target diseases. Safety testing for viral conditions is proving to be one of the primary concerns of most companies as it is a critical component of manufacturing, chemistry, and control of biologics. This is fueling growth opportunities in the market.

Laboratory-based contamination is leading to the development and refinement of workstations by incorporating biological safety products and services. The increasing need to work with tissue cultures, maintain the sterility of cell lines, and minimize cross-contamination has increased concerns regarding product integrity. Rising involvement by government healthcare organizations for implementing good manufacturing practices and subsequent testing & control at every production stage is expected to widen the scope for growth.

Furthermore, key players operating in the biological safety testing product & services market are constantly focusing on developing novel products and technologies, further expanding their product portfolio, and to meet the rising demand for biological safety testing globally. For instance, in December 2022, -Charles River Laboratories International, Inc. announced the launch of Endosafe Nexus 200, a fully robotic instrument capable of processing both complex or undiluted, serial dilutions for water, in-process, and final product testing, further expanding its endotoxin testing portfolio. The incorporation of automation through robotics has enabled streamlining the quality control process and subsequently improving overall process efficiency.

Biological Safety Testing Products And Services Market Report Highlights:

• Based on product, the reagents and kits segment held a leading revenue share of over 39.9% in 2023due to their extensive use in research and clinical laboratories
• Based on application, the vaccines & therapeutics segment dominated in terms of market share in 2023 and is anticipated to grow at fastest growth rate owing to the increase in disease outbreaks over the years
• Based on test type, the endotoxin tests segment dominated in terms of the market share of in 2023 owing to the rising prevalence of bacterial infections
• North America dominated the overall market with a revenue share of 35.13% in 2023, owing to rising research investments in biotechnology and the growing burden of chronic diseases. This anticipates increasing the demand for molecular cytogenetics in the region over the forecast period
• Asia Pacific is anticipated to grow at the fastest growth rate over the forecast period due to growing healthcare spending and the development of healthcare infrastructure in developing countries like India and China

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Segment Definitions
    • 1.1.1.1. Product Segment
    • 1.1.1.2. Application Segment
    • 1.1.1.3. Test Type Segment
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Objectives
  • 1.4.1. Objective - 1
  • 1.4.2. Objective - 2
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary Research
• 1.7. Information or Data Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Primary Sources
• 1.11. List of Abbreviations

Chapter 2. Biological Safety Testing Products & Services Market: Executive Summary

• 2.1. Market Snapshot
• 2.2. Products and Services Snapshots
• 2.3. Application And End-use Snapshot
• 2.4. Competitive Landscape Snapshot

Chapter 3. Biological Safety Testing Products & Services Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
• 3.4. Market Drivers Analysis
  • 3.4.1. Increase number of government initiatives and recommendations
  • 3.4.2. Increasing production of new biologics due to high disease burden
  • 3.4.3. High R&D investments in clinical research and life sciences research
• 3.5. Market Restraint Analysis
  • 3.5.1. Time-consuming approval process
• 3.6. Biological Safety Testing Products & Services Market Analysis Tools
  • 3.6.1. Industry Analysis - Porter's Five Forces
    • 3.6.1.1. Supplier Power
    • 3.6.1.2. Buyer Power
    • 3.6.1.3. Substitution Threat
    • 3.6.1.4. Threat of New Entrant
    • 3.6.1.5. Competitive Rivalry
  • 3.6.2. PESTLE Analysis
    • 3.6.2.1. Political Landscape
    • 3.6.2.2. Economic Landscape
    • 3.6.2.3. Social Landscape
    • 3.6.2.4. Technological Landscape
    • 3.6.2.5. Environmental Landscape
    • 3.6.2.6. Legal Landscape

Chapter 4. Biological Safety Testing Products & Services Market: Products Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Biological Safety Testing Products & Services Market By Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 To 2030 For The Following
  • 4.4.1. Reagents & Kits
    • 4.4.1.1. Market Estimates and Forecasts 2018 To 2030, (USD Million)
  • 4.4.2. Services
    • 4.4.2.1. Market Estimates and Forecasts 2018 To 2030, (USD Million)
  • 4.4.3. Instruments
    • 4.4.3.1. Market Estimates and Forecasts 2018 To 2030, (USD Million)

Chapter 5. Biological Safety Testing Products & Services Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Biological Safety Testing Products & Services Market By Application Outlook
• 5.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
  • 5.4.1. Vaccine & Therapeutics Market Revenue Estimates and Forecasts (USD Million, 2018 - 2030)
    • 5.4.1.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 5.4.1.1.1. Vaccines Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 5.4.1.1.1.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 5.4.1.1.2. Monoclonal Antibodies Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 5.4.1.1.2.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 5.4.1.1.3. Recombinant Protein Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 5.4.1.1.3.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 5.4.2. Blood & Blood-based Products Market Revenue Estimates and Forecasts (USD Million, 2018 - 2030)
    • 5.4.2.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 5.4.3. Gene Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 5.4.4. Tissue & Tissue-based Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 5.4.5. Stem Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)

Chapter 6. Biological Safety Testing Products & Services Market: Test Type Estimates & Trend Analysis

• 6.1. Test Type Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Biological Safety Testing Products & Services Market By Test Type Outlook
• 6.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
  • 6.4.1. Endotoxin Tests
    • 6.4.1.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 6.4.2. Sterility Tests
    • 6.4.2.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 6.4.3. Cell Line Authentication & Characterization Tests
    • 6.4.3.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 6.4.4. Bioburden Tests
    • 6.4.4.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 6.4.5. Adventitious Agent Detection Tests
    • 6.4.5.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 6.4.6. Residual Host Contamination Detection Tests
    • 6.4.6.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 6.4.7. Others
    • 6.4.7.1. Market Estimates And Forecasts (USD Million, 2018 - 2030)

Chapter 7. Regional Business Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key Country Dynamics
    • 7.5.1.2. Competitive Scenario
    • 7.5.1.3. Regulatory Framework
    • 7.5.1.4. U.S. Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.5.2. Canada
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Canada Market Estimates And Forecasts (USD Million, 2018 - 2030)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key Country Dynamics
    • 7.6.1.2. Competitive Scenario
    • 7.6.1.3. Regulatory Framework
    • 7.6.1.4. UK Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.6.2. Germany
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Germany Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.6.3. Spain
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Spain Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. France Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Italy Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.6.6. Denmark
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Denmark Market Estimates And Forecasts (USD Million, 2018 - 2030)
    • 7.6.6.5.
  • 7.6.7. Sweden
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Sweden Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.6.8. Norway
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Competitive Scenario
    • 7.6.8.3. Regulatory Framework
    • 7.6.8.4. Norway Market Estimates And Forecasts (USD Million, 2018 - 2030)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key Country Dynamics
    • 7.7.1.2. Competitive Scenario
    • 7.7.1.3. Regulatory Framework
    • 7.7.1.4. Japan Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.7.2. China
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. China Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.7.3. India
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. India Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.7.4. South Korea
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. South Korea Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.7.5. Thailand
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Thailand Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.7.6. Australia
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory Framework
    • 7.7.6.4. Australia Market Estimates And Forecasts (USD Million, 2018 - 2030)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key Country Dynamics
    • 7.8.1.2. Competitive Scenario
    • 7.8.1.3. Regulatory Framework
    • 7.8.1.4. Brazil Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.8.2. Mexico
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Mexico Biological Safety Testing Products & Services Market, 2018 - 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Argentina Market Estimates And Forecasts (USD Million, 2018 - 2030)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key Country Dynamics
    • 7.9.1.2. Competitive Scenario
    • 7.9.1.3. Regulatory Framework
    • 7.9.1.4. South Africa Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory Framework
    • 7.9.2.4. Saudi Arabia Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.9.3. UAE
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory Framework
    • 7.9.3.4. UAE Market Estimates And Forecasts (USD Million, 2018 - 2030)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Competitive Scenario
    • 7.9.4.3. Regulatory Framework
    • 7.9.4.4. Kuwait Market Estimates And Forecasts (USD Million, 2018 - 2030)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company /Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of Key Distributors And Channel Partners
  • 8.3.2. Key Customers
  • 8.3.3. Key Company Market Share Analysis, 2023
  • 8.3.4. Charles River Laboratories
    • 8.3.4.1. Overview
    • 8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.4.3. Product Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. BSL Bioservice
    • 8.3.5.1. Overview
    • 8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.5.3. Product Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Merck KGaA
    • 8.3.6.1. Overview
    • 8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.6.3. Product Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Samsung Biologics
    • 8.3.7.1. Overview
    • 8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.7.3. Product Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. Sartorius AG
    • 8.3.8.1. Overview
    • 8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.8.3. Product Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Eurofins Scientific
    • 8.3.9.1. Overview
    • 8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.9.3. Product Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. SGS Societe Generale de Surveillance SA
    • 8.3.10.1. Overview
    • 8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.10.3. Product Benchmarking
    • 8.3.10.4. Strategic Initiatives
  • 8.3.11. Thermo Fisher Scientific Inc.
    • 8.3.11.1. Overview
    • 8.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.11.3. Product Benchmarking
    • 8.3.11.4. Strategic Initiatives
  • 8.3.12. BIOMERIEUX
    • 8.3.12.1. Overview
    • 8.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.12.3. Product Benchmarking
    • 8.3.12.4. Strategic Initiatives
  • 8.3.13. Lonza
    • 8.3.13.1. Overview
    • 8.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.13.3. Product Benchmarking
    • 8.3.13.4. Strategic Initiatives